Logo image of AXGN

AXOGEN INC (AXGN) Stock Fundamental Analysis

NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD

18  -0.5 (-2.7%)

After market: 13.46 -4.54 (-25.22%)

Fundamental Rating

3

AXGN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. The financial health of AXGN is average, but there are quite some concerns on its profitability. AXGN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AXGN had negative earnings in the past year.
In the past year AXGN has reported a negative cash flow from operations.
In the past 5 years AXGN always reported negative net income.
AXGN had a negative operating cash flow in each of the past 5 years.
AXGN Yearly Net Income VS EBIT VS OCF VS FCFAXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.45%, AXGN is in the better half of the industry, outperforming 61.70% of the companies in the same industry.
AXGN's Return On Equity of -14.39% is fine compared to the rest of the industry. AXGN outperforms 62.77% of its industry peers.
Industry RankSector Rank
ROA -7.45%
ROE -14.39%
ROIC N/A
ROA(3y)-12.93%
ROA(5y)-13.89%
ROE(3y)-25.1%
ROE(5y)-23.33%
ROIC(3y)N/A
ROIC(5y)N/A
AXGN Yearly ROA, ROE, ROICAXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 76.13%, AXGN belongs to the top of the industry, outperforming 87.77% of the companies in the same industry.
In the last couple of years the Gross Margin of AXGN has remained more or less at the same level.
AXGN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.11%
GM growth 5Y-1.05%
AXGN Yearly Profit, Operating, Gross MarginsAXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

AXGN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AXGN has more shares outstanding
Compared to 5 years ago, AXGN has more shares outstanding
The debt/assets ratio for AXGN is higher compared to a year ago.
AXGN Yearly Shares OutstandingAXGN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
AXGN Yearly Total Debt VS Total AssetsAXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 4.34 indicates that AXGN is not in any danger for bankruptcy at the moment.
AXGN's Altman-Z score of 4.34 is fine compared to the rest of the industry. AXGN outperforms 75.53% of its industry peers.
AXGN has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.48, AXGN is doing worse than 61.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z 4.34
ROIC/WACCN/A
WACC8.74%
AXGN Yearly LT Debt VS Equity VS FCFAXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 3.74 indicates that AXGN has no problem at all paying its short term obligations.
AXGN has a better Current ratio (3.74) than 68.62% of its industry peers.
AXGN has a Quick Ratio of 2.47. This indicates that AXGN is financially healthy and has no problem in meeting its short term obligations.
AXGN has a Quick ratio (2.47) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.74
Quick Ratio 2.47
AXGN Yearly Current Assets VS Current LiabilitesAXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

AXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
AXGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.79%.
The Revenue has been growing by 13.64% on average over the past years. This is quite good.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y12.29%
Revenue growth 5Y13.64%
Sales Q2Q%17.86%

3.2 Future

AXGN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.06% yearly.
Based on estimates for the next years, AXGN will show a quite strong growth in Revenue. The Revenue will grow by 13.03% on average per year.
EPS Next Y144.39%
EPS Next 2Y94.79%
EPS Next 3Y69.08%
EPS Next 5Y46.06%
Revenue Next Year17.9%
Revenue Next 2Y15.4%
Revenue Next 3Y14.41%
Revenue Next 5Y13.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
AXGN Yearly Revenue VS EstimatesAXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
AXGN Yearly EPS VS EstimatesAXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 55.73, AXGN can be considered very expensive at the moment.
AXGN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXGN is cheaper than 69.15% of the companies in the same industry.
AXGN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE N/A
Fwd PE 55.73
AXGN Price Earnings VS Forward Price EarningsAXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXGN Per share dataAXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

AXGN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AXGN's earnings are expected to grow with 69.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y94.79%
EPS Next 3Y69.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXGN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXOGEN INC

NASDAQ:AXGN (2/21/2025, 8:02:29 PM)

After market: 13.46 -4.54 (-25.22%)

18

-0.5 (-2.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-25 2025-02-25/amc
Inst Owners75.91%
Inst Owner Change-0.45%
Ins Owners1.77%
Ins Owner Change0.31%
Market Cap792.18M
Analysts84.62
Price Target19.23 (6.83%)
Short Float %4.51%
Short Ratio4.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)670.83%
Min EPS beat(2)216.16%
Max EPS beat(2)1125.49%
EPS beat(4)4
Avg EPS beat(4)348.55%
Min EPS beat(4)13.49%
Max EPS beat(4)1125.49%
EPS beat(8)8
Avg EPS beat(8)211.72%
EPS beat(12)11
Avg EPS beat(12)154.79%
EPS beat(16)15
Avg EPS beat(16)125.74%
Revenue beat(2)2
Avg Revenue beat(2)4.79%
Min Revenue beat(2)1.33%
Max Revenue beat(2)8.25%
Revenue beat(4)3
Avg Revenue beat(4)1.82%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)8.25%
Revenue beat(8)5
Avg Revenue beat(8)0.32%
Revenue beat(12)6
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)0.37%
PT rev (1m)1.54%
PT rev (3m)14.78%
EPS NQ rev (1m)27.27%
EPS NQ rev (3m)27.27%
EPS NY rev (1m)2.17%
EPS NY rev (3m)123.8%
Revenue NQ rev (1m)1.34%
Revenue NQ rev (3m)0.43%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.73
P/S 4.38
P/FCF N/A
P/OCF N/A
P/B 7.97
P/tB 8.41
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.32
Fwd EY1.79%
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.11
BVpS2.26
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -14.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.13%
FCFM N/A
ROA(3y)-12.93%
ROA(5y)-13.89%
ROE(3y)-25.1%
ROE(5y)-23.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.11%
GM growth 5Y-1.05%
F-Score4
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 72.77%
Cap/Sales 3.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.74
Quick Ratio 2.47
Altman-Z 4.34
F-Score4
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)642.25%
Cap/Depr(5y)757.26%
Cap/Sales(3y)15.67%
Cap/Sales(5y)14.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y144.39%
EPS Next 2Y94.79%
EPS Next 3Y69.08%
EPS Next 5Y46.06%
Revenue 1Y (TTM)18.79%
Revenue growth 3Y12.29%
Revenue growth 5Y13.64%
Sales Q2Q%17.86%
Revenue Next Year17.9%
Revenue Next 2Y15.4%
Revenue Next 3Y14.41%
Revenue Next 5Y13.03%
EBIT growth 1Y64.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year221.57%
EBIT Next 3Y67.59%
EBIT Next 5YN/A
FCF growth 1Y75.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.75%
OCF growth 3YN/A
OCF growth 5YN/A